Rosuvastatin 3 times a week

ROSUVASTATIN should be discontinued or the dose reduced if the level of transaminases is greater than 3 times the upper limit of normal. ROSUVASTATIN, as well

the documented LFTs were 3 times. Figure 3. Providers Managing Therapy (n Once-a-week rosuvastatin (2.5 to 20 mg) in pa- tients with a previous

Week 3, 0.5 mg 3 times a day Week 4, 0.75 mg 3 times a day Week 5, 1 mg 3 times a day Week 6, 1.25 mg 3 times a day Week 7, 1.5 mg 3 times a day. -When used in combination with levodopa, the levodopa dose was reduced by an average of 27% from baseline providing a concomitant dose of approximately 800 mg per day. Extended-release:

Using rosuvastatin as infrequently as 3 times a week (approximately 30 mg/wk), helped achieve approximately a 34% reduction in LDL-C. However, some patients

Prescribing rosuvastatin. Rosuvastatin is prescribed once daily and can be taken at any time of day (Table 3). Patients should have their LDL-C

Using rosuvastatin as infrequently as 3 times a week (approximately 30 mg/wk), helped achieve approximately a 34% reduction in LDL-C. However, some patients

time (days to weeks). In animal studies, rosuvastatin was shown to be in breast milk at three times higher concentrations than measured in

of atorvastatin, then use ROSUVASTATIN If less than 3 times the upper limit of normal ( 120) can continue statin with monitoring. Recheck in 4 weeks, if

8 weeks treatment with either rosuvastatin 40 mg or atorvastatin 80 mg. Should an increase in ALT or AST of 3 times ULN persist, reduction of dose or